Piper Sandler initiated coverage on Sagimet Biosciences with a new price target
$SGMT
Biotechnology: Pharmaceutical Preparations
Health Care
Piper Sandler initiated coverage of Sagimet Biosciences with a rating of Overweight and set a new price target of $67.00